Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-09 Purchase | 2024-08-12 5:23 pm | Gain Therapeutics Inc. | GANX | Mack Gene CFO and Interim CEO | 14,400 | $1.01 | $14,544 | 14,400 (Direct) | View |
| 2024-08-09 Purchase | 2024-08-12 5:23 pm | Gain Therapeutics Inc. | GANX | Islam Khalid Executive Chairman | 50,000 | $0.9988 | $49,940 | 930,784 (Indirect Direct) | View |
| 2024-07-01 Purchase | 2024-07-01 5:00 pm | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 17,000 | $1.2159 | $20,670 | 304,458 (Indirect Direct) | View |
| 2024-03-28 Purchase | 2024-04-01 4:01 pm | Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director | 30,000 | $3.859 | $115,770 | 30,000 (Direct) | View |
| 2023-12-21 Sale | 2023-12-22 4:17 pm | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 206 | $2.46 | $507 | 12,299 (Direct) | View |
| 2023-12-07 Sale | 2023-12-14 4:01 pm | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 1,820 | $2.5 | $4,550 | 4,855 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | Islam Khalid Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | HASLER HANS PETER Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | Nicaise Claude Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-08 7:44 pm | N/A 2034-04-08 | Gain Therapeutics Inc. | GANX | Mack Gene Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-28 9:00 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 20,212 | $0 | 92,016 (Direct) | View |
| 2024-03-26 Tax Withholding | 2024-03-28 9:00 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 6,085 | $4.06 | 92,016 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 9:30 pm | N/A 2034-03-21 | Gain Therapeutics Inc. | GANX | Fuggetta Gianluca See Remark | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 9:30 pm | N/A 2034-03-21 | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 370,000 | $0 | 370,000 (Direct) | View |
| 2023-12-20 Exercise | 2023-12-22 4:17 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 637 | $0 | 12,299 (Direct) | View |
| 2023-10-01 Exercise | 2023-10-03 4:36 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 825 | $0 | 15,750 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-22 4:34 pm | N/A N/A | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 54,900 | $0 | 287,458 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-22 4:34 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 2,550 | $0 | 13,500 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 4:18 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 3,300 | $0 | 13,200 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:40 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | Islam Khalid Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:39 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:38 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:38 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:37 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | Nicaise Claude Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:36 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | HASLER HANS PETER Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-04-10 Option Award | 2023-04-12 5:36 pm | N/A 2033-04-10 | Gain Therapeutics Inc. | GANX | Ballantyne Charles Evan Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-03-23 Option Award | 2023-03-27 5:28 pm | N/A 2033-03-23 | Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-03-23 Option Award | 2023-03-27 5:27 pm | N/A 2033-03-23 | Gain Therapeutics Inc. | GANX | Fuggetta Gianluca Principal Accounting Officer | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-03-23 Option Award | 2023-03-27 5:26 pm | N/A 2033-03-23 | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 225,000 | $0 | 225,000 (Direct) | View |
Ownership | 2022-12-21 4:14 pm | N/A 2032-06-30 | Gain Therapeutics Inc. | GANX | Fuggetta Gianluca Principal Accounting Officer | 0 | $0 | 10,000 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:14 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 384,300 | $0 | 384,300 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:13 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Islam Khalid Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:11 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:10 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:09 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:08 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Nicaise Claude Director | 10,500 | $0 | 10,500 (Direct) | View |